4//SEC Filing
Anderton Robert M 4
Accession 0001209191-10-026150
CIK 0000811240other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:10 PM ET
Size
6.6 KB
Accession
0001209191-10-026150
Insider Transaction Report
Form 4
Anderton Robert M
Director
Transactions
- Award
Stock Option (right to buy)
2010-05-05+20,000→ 20,000 totalExercise: $1.90Exp: 2020-05-05→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Each automatic option is immediately exercisable for all of the option shares. However, any shares purchased under such option are subject to repurchase by the Issuer, at the lower of the exercise price paid per share or the fair market value per share (determined at the time of repurchase), should the Reporting Person cease Board service prior to vesting of those shares. The shares vest, and the Company's right of repurchase lapses, in four successive quarterly installments upon the Reporting Person's completion of each quarter of service as a non-employee director measured from the grant date. The shares subject to the option grant will immediately vest in full if certain changes in control or ownership occur or if the Reporting Person dies or becomes disabled while serving as a director.
Documents
Issuer
BIOLASE TECHNOLOGY INC
CIK 0000811240
Entity typeother
Related Parties
1- filerCIK 0001295300
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 5:10 PM ET
- Size
- 6.6 KB